The company is now working with compounding pharmacies to sell the 2 components of their products (Lidocain and Heparin) directly to docts' offices. This has zero impact on pps. I emailed the management, and he told me nothing else other than this info, which is nothing.
Is any one else in this stock. Yahoo still has 1-yr target price at $ 9 (nine dollars). see yahoo finance page.
